Combined Cytomegalovirus Prophylaxis in Lung Transplantation: Effects on Acute Rejection, Lymphocytic Bronchitis/Bronchiolitis, and Herpesvirus Infections

Transplantation Proceedings

Volumn 40, Issue 6, 2008, Pages 2013-2014

  Solidoro, P ^a   Libertucci, D ^a   Delsedime, L ^a   Ruffini, E ^a   Bosco, M ^a   Costa, C ^a   Rinaldi, M ^a   Baldi, S ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; IMMUNOGLOBULIN G; VALGANCICLOVIR; VIRUS DNA;

ARTICLE; BRONCHIOLITIS; BRONCHITIS; BRONCHUS BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA DETERMINATION; EPSTEIN BARR VIRUS; GRAFT RECIPIENT; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; INFECTION PREVENTION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; PRIORITY JOURNAL; VIRUS CULTURE;

ACYCLOVIR; ANTIVIRAL AGENTS; BIOPSY; BRONCHIOLITIS; BRONCHITIS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; GRAFT REJECTION; HERPESVIRIDAE INFECTIONS; HUMANS; LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 48049120457     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.05.028     Document Type: Article

References (4)

1. Bauer C.C., Jaksch P., Aberle S.W., et al. Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol 45 (2007) 324
2. Peskovitz M.D. Benefits of cytomegalovirus prophylaxis in solid organ transplantation. Transplantation 82 2S (2006) 4
3. Tikkanen J.M., Kallio E.A., Bruggeman C.A., et al. Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by antiviral prophylaxis or immunosuppression in rat tracheal allografts. Am J Respir Crit Care Med 164 (2001) 672
4. Ruttmann E., Geltner C., Bucher B., et al. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Transplantation 81 (2006) 1415